Biotech | November 30, 2021
Galderma acquires ALASTIN Skincare to enhance its dermatology platform
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
_256_384.jpg)
Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
With the launch of QurOne, the brand aims to redefine healthcare in the country with seamless, hassle-free patient care and hyper-coordinated workflows
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
The trial met the primary endpoint of overall survival with a single priming dose of tremelimumab plus Imfinzi every four weeks vs. sorafenib
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug
Subscribe To Our Newsletter & Stay Updated
